Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Mortensen, R. R. Dodge, T. Sparre, J. Raastam, J. Madsen, J. B. Kristensen, J. Marving (Copenhagen, Gentofte, Maaloev, Denmark). Lung deposition of inhaled radio-labelled human insulin. Eur Respir J 2008; 32: Suppl. 52, 4281

Member's Comments

No comment yet.

Related content which might interest you: Deposition and metabolism of inhaled ciclesonide in the human lung Source: Eur Respir J 2010; 36: 1113-1119 Year: 2010 Lung deposition distribution in astmatic patients of inhaled steroids when inhaled at the same time or 15 minutes after formoterol Source: Eur Respir J 2004; 24: Suppl. 48, 502s Year: 2004 Inhaled insulin does not trigger lung inflammation and airway remodelling Source: Eur Respir J 2009; 33: 444-445 Year: 2009 Calculation of peripheral airspace dimensions from deposition of inhaled nanoparticles Source: International Congress 2016 – Monitoring airway diseases with different tools Year: 2016 Bodyplethysmography during bronchoconstriction induced by inhaled histamine Source: International Congress 2014 – Airways: reversibility and responsiveness Year: 2014 Lung absorption half-life of inhaled drugs can be predicted with rat lung slices Source: International Congress 2015 – New models for treating airway diseases Year: 2015 Efficient deposition and absorption of orally inhaled indacaterol in the lungs Source: Annual Congress 2011 - COPD management Year: 2011 Small airway function in asthma patients treated with an ultrafine inhaled steroid aerosol Source: Eur Respir J 2004; 24: Suppl. 48, 581s Year: 2004 High lung deposition of 99mTc-labelled ciclesonide administered via HFA-MDI to asthma patients Source: Eur Respir J 2004; 24: Suppl. 48, 583s Year: 2004 Exposure of human subcutaneous adipose tissue and skeletal muscle tissue to unbound active drug after inhalation of high-dose ciclesonide or budesonide Source: Eur Respir J 2007; 30: Suppl. 51, 351s Year: 2007 Controlled inhalation improves total and peripheral lung deposition in CF Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis Year: 2019 Lung deposition of extrafine inhaled corticosteroid (ICS)-containing fixed combinations drug in COPD patients using Functional Respiratory Imaging (FRI). Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies Year: 2018 Blood eosinophils do not predict inhaled budesonide response in bronchiectasis Source: Eur Respir J, 56 (3) 2002210; 10.1183/13993003.02210-2020 Year: 2020 Throat deposition of inhaled drug can explain the variability in lung deposition Source: Eur Respir J 2005; 26: Suppl. 49, 276s Year: 2005 Inhaled long-acting β2-agonist: aerosol particle size and bronchodilator response Source: Eur Respir J 2005; 26: Suppl. 49, 126s Year: 2005 Slow particle dissolution may limit lung absorption of inhaled pharmaceuticals in the lungs Source: Eur Respir J 2006; 28: Suppl. 50, 210s Year: 2006 Effect of inhaled corticosteroids over glucose metabolism Source: Eur Respir J 2002; 20: Suppl. 38, 303s Year: 2002 Lung deposition of an aerosol produced by a new inhalation device for ventilated patients Source: Eur Respir J 2005; 26: Suppl. 49, 88s Year: 2005 Reduced uptake of inhaled carbon in airway macrophages from children with cystic fibrosis Source: International Congress 2018 – Latest developments in cystic fibrosis Year: 2018 Deposition of inhaled nanoparticles, airflow obstruction and emphysema Source: International Congress 2016 – Pulmonary drug delivery Year: 2016